Trandolapril NEW
| Price | $39 | $64 | $115 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Trandolapril | CAS No.: 87679-37-6 |
| Purity: 99.70% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Trandolapril |
| Description | Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that is hydrolysed to the active diacid trandolaprilat. |
| Storage | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : < 10 mg/mL (23.23 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+90% Saline : < 10 mg/mL (23.23 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. DMSO : 100 mg/mL (232.27 mM), Sonication is recommended. |
| Keywords | UUO model | UUD model | unilateral ureteral obstruction | Trandolaprilat | Trandolapril | spontaneously hypertensive rats | RU-44570 | RU44570 | RU 44570 | orally active | nonsulfhydryl | myocardial infarction | Inhibitor | inhibit | hypertension | congestive heart failure | collagen | CHF | cellular fibronectin accumulation | arterial hypertrophy | AngiotensinconvertingEnzyme(ACE) | AngiotensinconvertingEnzyme | Angiotensin-converting Enzyme (ACE) | Angiotensinconverting Enzyme (ACE) | Angiotensin-converting Enzyme | ACE |
| Inhibitors Related | H-ASP-PHE-OH | Fosinopril sodium | Enalapril Maleate | Lisinopril dihydrate | N-Valyltryptophan | Ceronapril | Ursodeoxycholic acid | Sinapinic Acid | Lisinopril | Ramipril | Captopril | BNC210 |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Drug-induced Liver Injury (DILI) Compound Library | Toxic Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cardiovascular Disease Compound Library | FDA-Approved Drug Library | Metabolism Compound Library | Orally Active Compound Library | Bioactive Compounds Library Max | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-30 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $560.00 |
VIP5Y
|
Hebei Dangtong Import and export Co LTD
|
2026-02-25 | |
| $50.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-25 | ||
| $200.00 |
Hebei Mingeng Biotechnology Co., Ltd
|
2023-06-26 | ||
| $100.00 |
Shijiazhuang Gantuo Biotechnology Co., Ltd
|
2023-04-11 | ||
| $200.00 |
Hebei Best Biological Technology Co., Ltd
|
2022-12-01 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY